Search research articles
Contact Us
Filters
Showing results (31-40 of 327) with videos related to
Page
of 33
Sort By:
The Journal of Laboratory and Clinical Medicine
|
August 1, 1991
Compositional changes in lipoproteins of subjects with non-insulin-dependent diabetes mellitus
S M Haffner
Endocrine Reviews
|
October 30, 1998
The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease
S M Haffner
Diabetes Care
|
March 1, 1996
Insulin resistance and atherosclerosis
A Garg, S M Haffner
Managed Care Interface
|
November 7, 2000
Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agents
S M Haffner, T Ashraf
The American Journal of Medicine
|
August 1, 1997
Insulin resistance implications for type II diabetes mellitus and coronary heart disease
S M Haffner, H Miettinen
Diabetes Care
|
December 1, 1991
Dyslipidemia in type II diabetes. Implications for therapeutic intervention
M P Stern, S M Haffner
Diabetes/Metabolism Reviews
|
February 1, 1990
Type II diabetes and its complications in Mexican Americans
M P Stern, S M Haffner
The American Journal of Medicine
|
January 16, 1995
Endogenous sex hormones: impact on lipids, lipoproteins, and insulin
S M Haffner, R A Valdez
Arteriosclerosis (Dallas, Tex.)
|
March 1, 1986
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease
M P Stern, S M Haffner
Metabolism: Clinical and Experimental
|
June 1, 1993
The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women
S M Haffner, R L Bauer
Page
of 33
Search research articles
Search
Showing results (31-40 of 327) with videos related to
Sort By:
Page
of 33
The Journal of Laboratory and Clinical Medicine
|
August 1, 1991
Compositional changes in lipoproteins of subjects with non-insulin-dependent diabetes mellitus
S M Haffner
Endocrine Reviews
|
October 30, 1998
The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease
S M Haffner
Diabetes Care
|
March 1, 1996
Insulin resistance and atherosclerosis
A Garg, S M Haffner
Managed Care Interface
|
November 7, 2000
Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agents
S M Haffner, T Ashraf
The American Journal of Medicine
|
August 1, 1997
Insulin resistance implications for type II diabetes mellitus and coronary heart disease
S M Haffner, H Miettinen
Diabetes Care
|
December 1, 1991
Dyslipidemia in type II diabetes. Implications for therapeutic intervention
M P Stern, S M Haffner
Diabetes/Metabolism Reviews
|
February 1, 1990
Type II diabetes and its complications in Mexican Americans
M P Stern, S M Haffner
The American Journal of Medicine
|
January 16, 1995
Endogenous sex hormones: impact on lipids, lipoproteins, and insulin
S M Haffner, R A Valdez
Arteriosclerosis (Dallas, Tex.)
|
March 1, 1986
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease
M P Stern, S M Haffner
Metabolism: Clinical and Experimental
|
June 1, 1993
The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women
S M Haffner, R L Bauer
Page
of 33